# Telix Pharmaceuticals Ltd: Form 6-K, filed May 21, 2026

- Company: [Telix Pharmaceuticals Ltd](/companies/tlx.md) (CIK 2007191)
- Form: 6-K
- Filed: 2026-05-21
- Accepted by EDGAR: May 21, 2026, 16:10 ET
- Period: 2025-05-20
- Accession: 0002007191-26-000027
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2007191/000200719126000027/agmresults6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007191/000200719126000027/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007191/000200719126000027/agmresults6k.htm

Filed May 21, 2026.
Source: SEC EDGAR, the filing index for accession 0002007191-26-000027. Last ingested by Listed: Oct 29, 2026, 16:54 ET. No prices; not investment advice.